openpharmaA project by Edozie
OPEN INFRASTRUCTURE FOR MEDICINE

Open science.
Accessible
medicine.

Building open tools for pharmaceutical research, evidence and manufacturing. A shared foundation for a future where more people can access the medicine they need.

Explore the modules See the roadmap

Early-stage project. Built in the open.

PLATFORM BLUEPRINTv0.0
+ One connected research stack +
01DiscoveryNew candidates. New possibilities.Drug discovery · Drug repurposing 02EvidenceFrom research question to review.Clinical evidence automation 03ManufacturingUnderstand the cost of making.Cost reduction · Lab in a box Shared datasets & models
All modules planned6 MODULES / 1 MISSION
BUILD STATUS

From zero to 1.0.
Every step, visible.

Overall product completion0%
0%
0 · Prototype starting point100 · Product 1.0

All six modules are at the planning stage. Progress will reflect completed, documented milestones.

THE BUILDING BLOCKS

Six modules.
One open foundation.

From the first research question to the economics of production. Explore what each module is being designed to do.

01 / 06
Manufacturing

Manufacturing cost reduction

Make the cost of making medicine visible. Explore equipment, process and production trade-offs in an open cost model.

Planned0%
0%
Explore module

First prototype

A transparent cost calculator for one reference manufacturing process, with editable assumptions and a downloadable breakdown.

Product 1.0 target

Versioned process models, equipment comparisons and documented benchmarks reviewed with manufacturing specialists.

Planned outputs

  • Cost models
  • Equipment comparisons
  • Process benchmarks
02 / 06
Infrastructure

Lab in a box

Design a modular research workspace. Bring equipment specifications, workflow software and reproducible experiments together.

Planned0%
0%
Explore module

First prototype

A reference equipment inventory and simulated workflow for one research task, with the bill of materials published alongside it.

Product 1.0 target

Documented hardware interfaces, calibration records and repeatable workflows evaluated with a research lab.

Planned outputs

  • Hardware specifications
  • Workflow templates
  • Calibration records
03 / 06
Evidence

Clinical evidence automation

Connect the evidence workflow end to end, from literature and protocol drafts to analysis and reporting, with expert review at each decision.

Planned0%
0%
Explore module

First prototype

A cited evidence map for one research question, with traceable extraction, a draft protocol and a reproducible analysis on public data.

Product 1.0 target

An auditable research workflow with source checks, versioned analyses and explicit clinical, statistical and ethics review gates.

Planned outputs

  • Evidence maps
  • Protocol drafts
  • Reproducible analyses
04 / 06
Discovery

Drug discovery engine

Explore promising research directions with transparent models. Connect targets, molecular data and computational screening in one workflow.

Planned0%
0%
Explore module

First prototype

A reproducible benchmark on a public dataset that compares a baseline model with a documented candidate-ranking approach.

Product 1.0 target

Versioned screening workflows with benchmark results, uncertainty reporting and independent reproducibility checks.

Planned outputs

  • Screening workflows
  • Model benchmarks
  • Ranked hypotheses
05 / 06
Discovery

Drug repurposing engine

Investigate new research uses for existing medicines. Map drug, target and disease evidence to surface hypotheses worth testing.

Planned0%
0%
Explore module

First prototype

An evidence-linked map for a defined disease area, with ranked research hypotheses and a clear record of supporting and conflicting findings.

Product 1.0 target

A reproducible prioritisation workflow with transparent scoring, uncertainty and expert review before any experimental follow-up.

Planned outputs

  • Evidence graphs
  • Research hypotheses
  • Transparent scoring
06 / 06
Shared foundation

Datasets & models library

Give others a starting point they can reproduce. Catalogue datasets, models and experiments with provenance, licences and setup instructions.

Planned0%
0%
Explore module

First prototype

A searchable collection of reference datasets and models, with source links, licence notes and one fully reproducible example.

Product 1.0 target

Versioned collections, model and dataset cards, reproducible environments and documented replication results.

Planned outputs

  • Dataset & model cards
  • Replication guides
  • Versioned experiments

These are planned capabilities. Research outputs will need appropriate expert review and experimental validation.

THE ROAD TO 1.0

Build. Test. Reproduce.

A common milestone framework for every module, with evidence of progress published as the work develops.

  1. 0%
    STAGE 00 WE ARE HERE

    Starting point

    Define the problem, scope and first experiment.

  2. 25%
    STAGE 01

    Working prototype

    Demonstrate one useful workflow from input to output.

  3. 50%
    STAGE 02

    Reproducible results

    Publish benchmarks, methods and replication instructions.

  4. 75%
    STAGE 03

    Partner pilot

    Evaluate the workflow with researchers and domain specialists.

  5. 100%
    STAGE 04

    Product 1.0

    Release documented tools with defined limits and maintenance plans.

Percentages represent development milestones, not clinical validation or regulatory approval. Overall progress is the equal-weight average of the six modules.

WHY OPENPHARMA

Medicine is essential.
Access should be, too.

OpenPharma starts with a question: what becomes possible when the tools behind medicine are easier to inspect, reproduce and improve?

The ambition is more accessible medicine. The work starts with open software, transparent methods and a public record of what works, what fails and what comes next.

Follow the work
BUILDING IN PUBLIC

The work starts here.

A capstone project by Edozie. Follow the decisions, experiments and milestones from the first prototype onward.

PROJECT NOTE 001

The blueprint is open.

Six modules, one shared mission, and a starting point of 0%. This is the initial scope for OpenPharma. The next step is to define and build the first reproducible prototype.

Meet the builder